Radiopharm Theranostics, a cutting-edge biotechnology company, is set to make its mark on the NASDAQ by the end of 2024. The company’s innovative approach to theranostics, a field that combines therapeutic and diagnostic capabilities, has generated significant interest and excitement within the healthcare sector. At the core of Radiopharm Theranostics’ success lies its proprietary technology […]
![](https://richtradersknow.com/wp-content/uploads/2024/07/radiopharm-theranostics-bLgJew-800x533-1.png)